Home/Filings/4/0001294002-05-000027
4//SEC Filing

THEOFAN GEORGIA 4

Accession 0001294002-05-000027

CIK 0000817785other

Filed

Aug 9, 8:00 PM ET

Accepted

Aug 10, 5:06 PM ET

Size

4.8 KB

Accession

0001294002-05-000027

Insider Transaction Report

Form 4
Period: 2005-06-30
THEOFAN GEORGIA
VP, Clinical Development
Transactions
  • Award

    Common Stock

    2005-06-30$0.65/sh+5,385$3,50024,240 total
Footnotes (1)
  • [F1]Matching company contribution to 401K account.

Issuer

IMMUNE RESPONSE CORP

CIK 0000817785

Entity typeother

Related Parties

1
  • filerCIK 0001280158

Filing Metadata

Form type
4
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 5:06 PM ET
Size
4.8 KB